NCT01155154

Brief Summary

Research Question: In emergency department patients with simple hand cuts, do prophylactic antibiotics reduce the risk of wound infections?

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
73

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2010

Typical duration for not_applicable

Geographic Reach
1 country

3 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2010

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

June 29, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 1, 2010

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2012

Completed
2.8 years until next milestone

Results Posted

Study results publicly available

November 4, 2014

Completed
Last Updated

November 7, 2014

Status Verified

November 1, 2014

Enrollment Period

2 years

First QC Date

June 29, 2010

Results QC Date

January 3, 2014

Last Update Submit

November 3, 2014

Conditions

Keywords

wounds and lacerationshandinfectionAntibioticsantibacterial agents

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Presence of Wound Infection

    Hand lacerations will be examined 10-14 days after initial wound closure and will be assessed for presence of infection.

    2 weeks

Study Arms (3)

clindamycin

ACTIVE COMPARATOR

clindamycin 300 mg (two 150 mg capsules) every 6 hours for 7 days

Drug: clindamycin

cepahlexin

ACTIVE COMPARATOR
Drug: cephalexin

Placebo

PLACEBO COMPARATOR
Drug: placebo

Interventions

500 mg (two 250 mg capsules) every 6 hours for 7 days

cepahlexin

300 mg of clindamycin (two 150 mg capsules) every 6 hours for 7 days

clindamycin

Two placebo capsules every 6 hours for 7 days

Placebo

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All adult patients (≥ 18 years of age) presenting to the ED with simple hand lacerations. Anatomically, lacerations distal to the radial carpal ligament will be considered "hand" lacerations. "Simple" or "uncomplicated" laceration refers to one that does not involve any special tissue (bone, tendon, blood vessel, or nerve).

You may not qualify if:

  • Immunocompromised patients (cancer, chemotherapy, transplant, HIV/AIDs)
  • Current or recent (within two weeks) use of any antibiotics
  • Allergy to clindamycin or cephalexin
  • Bites (e.g. dog, cat, or human)
  • Lacerations resulted from crush injury
  • Lacerations involving bone, tendon, blood vessel, or nerve
  • Lacerations inflicted more than 12 hours prior to ED visit
  • Pregnant or breast-feeding women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Kings County Hospital Center

Brooklyn, New York, 11203, United States

Location

State University of New York, Downstate Medical Center

Brooklyn, New York, 11203, United States

Location

Staten Island University Hospital

Staten Island, New York, 10305, United States

Location

MeSH Terms

Conditions

Wounds and InjuriesLacerationsInfections

Interventions

CephalexinClindamycin

Intervention Hierarchy (Ancestors)

Cephalosporinsbeta-LactamsLactamsAmidesOrganic ChemicalsThiazinesSulfur CompoundsHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsLincomycinLincosamidesPyrrolidinesHeterocyclic Compounds, 1-RingGlycosidesCarbohydrates

Results Point of Contact

Title
Shahriar Zehtabchi
Organization
SUNY Downstate Medical Center

Study Officials

  • shahriar zehtabchi, MD

    State University of New York - Downstate Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Emergency Medicine

Study Record Dates

First Submitted

June 29, 2010

First Posted

July 1, 2010

Study Start

February 1, 2010

Primary Completion

February 1, 2012

Study Completion

February 1, 2012

Last Updated

November 7, 2014

Results First Posted

November 4, 2014

Record last verified: 2014-11

Locations